VITAF — Pharmaceutical Centre SA Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.52% | ||
| Return on Equity | 6.4% | ||
| Operating Margin | 1.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 179.02 | 202.9 | 218.54 | 223.16 | 210.94 | n/a | n/a | 6.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +136 | +9.17 | +9.24 | +18.97 | -47.67 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmaceutical Centre SA is a Greece-based company primarily engaged in the pharmaceutical industry. The Company is active in the wholesale trade of pharmaceuticals, parapharmaceuticals and related products. The activities of the Company include the procurement, trade, distribution, import and export of medicines, pharmaceutical products and substances as well as medical supplies, cosmetics, dietary products, infant foods and hygiene items. The Company holds the required certification and a quality assurance system necessary for the distribution of its products. Pharmaceutical Centre SA operates pharmaceutical warehouses both in Greece and abroad and has a fleet of transport vehicles serving multiple sales points.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 17th, 1999
- Public Since
- January 21st, 2020
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Cyprus Stock Exchange
- Shares in Issue
- 19,494,313
- Address
- Chalkis 23, Pylaia, THESSALONIKI, 570 01
- Web
- https://www.lelosgroup.gr/vitafarm
- Phone
- +30 2316003100
- Auditors
- PKF Euroaudit SA
Upcoming Events for VITAF
Similar to VITAF
Meditrina Cyprus
Cyprus Stock Exchange
FAQ
What is the Pharmaceutical Centre SA share price?
As of Today at 22:37 UTC, shares in Pharmaceutical Centre SA are trading at €1.18. This share price information is delayed by 15 minutes.
How has the Pharmaceutical Centre SA share price performed this year?
Shares in Pharmaceutical Centre SA last closed at €1.18 and the price had moved by over the past 365 days. In terms of relative price strength the Pharmaceutical Centre SA share price has underperformed the FTSE Global All Cap Index by -2.5% over the past year.
What are the analyst and broker recommendations for Pharmaceutical Centre SA?
There is no consensus recommendation for this security.
Find out moreWhat is the Pharmaceutical Centre SA dividend yield?
Pharmaceutical Centre SA does not currently pay a dividend.
Does Pharmaceutical Centre SA pay a dividend?
Pharmaceutical Centre SA does not currently pay a dividend.
When does Pharmaceutical Centre SA next pay dividends?
Pharmaceutical Centre SA does not currently pay a dividend.
How do I buy Pharmaceutical Centre SA shares?
To buy shares in Pharmaceutical Centre SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharmaceutical Centre SA?
As of the previous close price of €1.18, shares in Pharmaceutical Centre SA had a market capitalisation of .
Where are Pharmaceutical Centre SA shares listed?
Here are the trading details for Pharmaceutical Centre SA:
- Country of listing: Cyprus
- Exchange: CYS
- Ticker Symbol: VITAF
What kind of share is Pharmaceutical Centre SA?
Based on an overall assessment of its quality, value and momentum Pharmaceutical Centre SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharmaceutical Centre SA share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Pharmaceutical Centre SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmaceutical Centre SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -0.13%.
As of the last closing price of €1.18, shares in Pharmaceutical Centre SA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharmaceutical Centre SA PE Ratio?
The Pharmaceutical Centre SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharmaceutical Centre SA?
We do not have data on Pharmaceutical Centre SA's directors